Why the study?
Are polypharmacy and potentially inappropriate medication associated with adverse outcomes and mortality in older cancer patients?
Population
Older cancer patients
Comparison
Polypharmacy and PIM use vs non-use
Design
Systematic review and meta-analysis
Authors
Loading...
May warrant medication review in older cancer patients; leaves open causal effects on outcomes.
Are polypharmacy and potentially inappropriate medication associated with adverse outcomes and mortality in older cancer patients?
Polypharmacy and potentially inappropriate medication use are associated with adverse outcomes and mortality in older cancer patients, though current evidence is heavily limited by confounding.
Chen et al. (2020) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: